Premium
Seroprevalence and factors associated with equine herpesvirus type 1 and 4 in Spanish Purebred horses in Spain
Author(s) -
Cruz F.,
Fores P.,
MughiniGras L.,
Ireland J.,
Moreno M. A.,
Newton J. R.
Publication year - 2016
Publication title -
veterinary record
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 99
eISSN - 2042-7670
pISSN - 0042-4900
DOI - 10.1136/vr.103573
Subject(s) - seroprevalence , purebred , veterinary medicine , population , horse , serology , medicine , vaccination , demography , biology , environmental health , crossbreed , virology , immunology , zoology , antibody , paleontology , sociology
Equine herpesvirus type 1 (EHV‐1) and type 4 (EHV‐4) have a worldwide distribution and cause respiratory disease, abortion, neonatal death and myeloencephalopathy in susceptible horses. Given the scarcity of serological EHV‐1/EHV‐4 data in Spain, the objective of this cross‐sectional study was to estimate the seroprevalence of EHV‐1/EHV‐4 and to identify potential horse‐level and stud farm‐level factors associated with EHV‐1/EHV‐4 in the breeding Spanish Purebred (SP) horse population in central Spain. Serum samples from 334 SP unvaccinated horses, collected between September 2011 and November 2013 at 30 stud farms, were tested using a commercially available EHV‐1/EHV‐4 antibody ELISA and seroneutralisation as the World Organisation for Animal Health reference confirmation test. Data on factors putatively associated with seropositivity to EHV‐1/EHV‐4 were collected via a questionnaire and examined using logistic regression analysis. EHV‐1/EHV‐4 seroprevalence in the SP breeding population in central Spain, standardised for the sex distribution of the reference horse population, was 53.9 per cent (95 per cent confidence interval 44.0 per cent to 63.8 per cent). Increasing age, southern location of the stud farm, temperate climate during the summer, and a smaller surface area used for breeding activities in the farm were associated with increased odds for EHV‐1/EHV‐4 seropositivity, whereas EHV‐1/EHV‐4 vaccination of other resident horses and separation of breeding mares from youngsters were protective factors.